Chicago, IL (PRWEB) January 24, 2008
ClearTrial, a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing, announced today that Kristin Lucas, Director of Account Management for ClearTrial, will share innovative strategies for optimizing clinical trial planning at the Center for Business Intelligence (CBI) Clinical Trial Forecasting and Budgeting Conference. The conference, to be held February 7-8 at the Marriott Philadelphia West in West Conshohocken, Pennsylvania, provides the pharmaceutical and biotechnology industry with the latest tools, technologies and methods for improving clinical trial feasibility, budget accuracy and contract negotiation.
During the conference, Ms. Lucas will present "Achieve Speed and Cost Savings when Using New Clinical Development Strategies" - a topic of ever-increasing importance given the rapid adoption of new clinical development strategies and technologies. She will review multiple new clinical development strategies, including the Functional Service Provider (FSP) outsourcing model, Electronic Data Capture (EDC), global studies, and preferred provider relationships, and highlight the areas in which clinical professionals should expect to find cost and time savings in a clinical budget and forecast. Just as importantly, Ms. Lucas will point to common pitfalls in these new strategies which often lead to hidden increases in clinical trial costs and time. The session will offer real-world examples of how organizations are dramatically compressing both the time and cost of clinical trial planning, forecasting and execution.
Ms. Lucas brings more than 14 years of experience in the pharmaceutical and biotech industry to the conference. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at ICOS Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Ms. Lucas was responsible for establishing best practices in the outsourcing, management, drafting and negotiation of site and vendor agreements, as well as the development of a clinical budgeting/modeling application for lifecycle planning, budgeting and in-licensing opportunity assessment. In addition, she led the Sarbanes-Oxley audit preparedness project, resulting in ICOS achieving SOX compliance in 2006. Prior to ICOS, Ms. Lucas spent seven years with Genentech, where she was responsible for the negotiation, positioning, and pricing strategy for managed care contracts. She has extensive education and training in project management, negotiation, costing of clinical studies, advanced financial modeling, and marketing and business administration.
About the Center for Business Intelligence
Founded in 1994 in Massachusetts, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticalsbiotech, medical devices, risk and insurance and managed care markets. CBI offers conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation. As a delegate, speaker or sponsor, attendees receive timely information on the latest investment opportunities, business strategies, domestic and international regulatory issues, operations and applied technologies. CBI events provide concrete, real life examples that attendees can begin to apply at their organizations immediately for significant impact on costs and revenue. For more information visit http://www.cbinet.com/.
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.
ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.
For more information, contact:
+1 630 424 1601 x102
# # #